Literature DB >> 6128617

Emergence of meningococcal meningitis caused by W 135 subgroup in Africa.

F Denis, J L Rey, A Amadou, P Saliou, M Prince-David, S M'Boup, M Cadox, I D Mar, J Etienne.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 6128617     DOI： 10.1016/s0140-6736(82)91533-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine.

Authors:  Christopher B Nelson; Maureen Birmingham; Alejandro Costa; Joelle Daviaud; William Perea; Marie-Paule Kieny; Daniel Tarantola
Journal:  Am J Public Health       Date:  2007-04-05       Impact factor: 9.308

2.  The changing face of meningococcal disease in West Africa.

Authors:  B Greenwood
Journal:  Epidemiol Infect       Date:  2007-07       Impact factor: 2.451

Review 3.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice.

Authors:  Zhigang Jin; Gregory A Bohach; Joseph Shiloach; Scott E Norris; Darón I Freedberg; Claudia Deobald; Bruce Coxon; John B Robbins; Rachel Schneerson
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 5.  Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.

Authors:  Mustapha M Mustapha; Lee H Harrison
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452

6.  Recent increase in meningitis Caused by Neisseria meningitidis serogroups A and W135, Yaoundé, Cameroon.

Authors:  Marie-Christine Fonkoua; Muhamed-Kheir Taha; Pierre Nicolas; Patrick Cunin; Jean-Michel Alonso; Raymond Bercion; Jeanne Musi; Paul M V Martin
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

7.  Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.

Authors:  Dominique A Caugant; Paul A Kristiansen; Xin Wang; Leonard W Mayer; Muhamed-Kheir Taha; Rasmata Ouédraogo; Denis Kandolo; Flabou Bougoudogo; Samba Sow; Laurence Bonte
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

8.  Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000.

Authors:  Jean-François Aguilera; Anne Perrocheau; Christine Meffre; Susan Hahné
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

9.  Polymerase chain reaction assay and bacterial meningitis surveillance in remote areas, Niger.

Authors:  Fati Sidikou; Saacou Djibo; Muhamed Kheir Taha; Jean Michel Alonso; Ali Djibo; Kiari Kaka Kairo; Suzanne Chanteau; Pascal Boisier
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

10.  Carriage of Neisseria meningitidis serogroup W135 ST-2881.

Authors:  Pascal Boisier; Pierre Nicolas; Saacou Djibo; Amina Amadou Hamidou; Bernard Tenebray; Raymond Borrow; Suzanne Chanteau
Journal:  Emerg Infect Dis       Date:  2006-09       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.